143 related articles for article (PubMed ID: 15951472)
1. Effect of simulated microgravity on the disposition and tissue penetration of ciprofloxacin in healthy volunteers.
Schuck EL; Grant M; Derendorf H
J Clin Pharmacol; 2005 Jul; 45(7):822-31. PubMed ID: 15951472
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose.
Wagenlehner FM; Kinzig-Schippers M; Tischmeyer U; Wagenlehner C; Sörgel F; Dalhoff A; Naber KG
Int J Antimicrob Agents; 2006 Jan; 27(1):7-14. PubMed ID: 16343856
[TBL] [Abstract][Full Text] [Related]
3. Penetration of ciprofloxacin and its desethylenemetabolite into skin in humans after a single oral dose of the parent drug assessed by cutaneous microdialysis.
Bielecka-Grzela S; Klimowicz A
J Clin Pharm Ther; 2005 Aug; 30(4):383-90. PubMed ID: 15985052
[TBL] [Abstract][Full Text] [Related]
4. Sex-related differences in the pharmacokinetics of oral ciprofloxacin.
Overholser BR; Kays MB; Forrest A; Sowinski KM
J Clin Pharmacol; 2004 Sep; 44(9):1012-22. PubMed ID: 15317829
[TBL] [Abstract][Full Text] [Related]
5. Effect of probenecid on the distribution and elimination of ciprofloxacin in humans.
Jaehde U; Sörgel F; Reiter A; Sigl G; Naber KG; Schunack W
Clin Pharmacol Ther; 1995 Nov; 58(5):532-41. PubMed ID: 7586947
[TBL] [Abstract][Full Text] [Related]
6. Assessment of bioequivalence of ciprofloxacin in healthy male subjects using HPLC.
Khan MK; Khan MF
Pak J Pharm Sci; 2008 Jul; 21(3):299-306. PubMed ID: 18614429
[TBL] [Abstract][Full Text] [Related]
7. Comparative bioequivalence and pharmacokinetics of ciprofloxacin in healthy male subjects.
Khan MK; Khan MF
Pak J Pharm Sci; 2009 Jan; 22(1):1-7. PubMed ID: 19168412
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of a novel extended-release ciprofloxacin in healthy volunteers.
Washington CB; Hou SY; Campanella C; Hughes N; Brown S; Berner B
J Clin Pharmacol; 2005 Nov; 45(11):1236-44. PubMed ID: 16239356
[TBL] [Abstract][Full Text] [Related]
9. Soft tissue concentrations of ciprofloxacin in obese and lean subjects following weight-adjusted dosing.
Hollenstein UM; Brunner M; Schmid R; Müller M
Int J Obes Relat Metab Disord; 2001 Mar; 25(3):354-8. PubMed ID: 11319632
[TBL] [Abstract][Full Text] [Related]
10. Ciprofloxacin and norfloxacin pharmacokinetics and prostatic fluid penetration in dogs after multiple oral dosing.
Albarellos GA; Montoya L; Waxman S; Kreil V; Ambros LA; Hallu R; Rebuelto M
Vet J; 2006 Sep; 172(2):334-9. PubMed ID: 15994101
[TBL] [Abstract][Full Text] [Related]
11. Plasma concentrations of enrofloxacin and its active metabolite ciprofloxacin in dogs following single oral administration of enrofloxacin at 7.5, 10, or 20 mg/kg.
Boothe DM; Boeckh A; Boothe HW; Wilkie S; Jones S
Vet Ther; 2002; 3(4):409-19. PubMed ID: 12584678
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and residues of ciprofloxacin and its metabolites in broiler chickens.
Anadón A; Martínez-Larrañaga MR; Iturbe J; Martínez MA; Díaz MJ; Frejo MT; Martínez M
Res Vet Sci; 2001 Oct; 71(2):101-9. PubMed ID: 11883887
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and tissue distribution of enrofloxacin and its active metabolite ciprofloxacin in calves.
Davis JL; Foster DM; Papich MG
J Vet Pharmacol Ther; 2007 Dec; 30(6):564-71. PubMed ID: 17991225
[TBL] [Abstract][Full Text] [Related]
14. Disposition kinetics of danofloxacin and ciprofloxacin in broiler chickens.
el-Gendi AY; el-Banna HA; Abo Norag M; Gaber M
Dtsch Tierarztl Wochenschr; 2001 Oct; 108(10):429-34. PubMed ID: 11721591
[TBL] [Abstract][Full Text] [Related]
15. Bioequivalence evaluation of two different formulations of ciprofloxacin tablets in healthy volunteers.
Hassan Y; Alfadly SO; Azmin MN; Peh KK; Tan TF; Noorizan AA; Ismail O
Singapore Med J; 2007 Sep; 48(9):819-23. PubMed ID: 17728962
[TBL] [Abstract][Full Text] [Related]
16. Concentrations in plasma, urinary excretion and bactericidal activity of levofloxacin (500 mg) versus ciprofloxacin (500 mg) in healthy volunteers receiving a single oral dose.
Wagenlehner FM; Kinzig-Schippers M; Sörgel F; Weidner W; Naber KG
Int J Antimicrob Agents; 2006 Dec; 28(6):551-9. PubMed ID: 17101261
[TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetics of orbifloxacin in the horse following oral and intravenous administration.
Davis JL; Papich MG; Weingarten A
J Vet Pharmacol Ther; 2006 Jun; 29(3):191-7. PubMed ID: 16669863
[TBL] [Abstract][Full Text] [Related]
18. Target site concentrations of ciprofloxacin after single intravenous and oral doses.
Brunner M; Stabeta H; Möller JG; Schrolnberger C; Erovic B; Hollenstein U; Zeitlinger M; Eichler HG; Müller M
Antimicrob Agents Chemother; 2002 Dec; 46(12):3724-30. PubMed ID: 12435668
[TBL] [Abstract][Full Text] [Related]
19. Plasma and interstitial fluid pharmacokinetics of enrofloxacin, its metabolite ciprofloxacin, and marbofloxacin after oral administration and a constant rate intravenous infusion in dogs.
Bidgood TL; Papich MG
J Vet Pharmacol Ther; 2005 Aug; 28(4):329-41. PubMed ID: 16050812
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and milk penetration of difloxacin after intravenous, subcutaneous and intramuscular administration to lactating goats.
Marín P; Escudero E; Fernández-Varón E; Cárceles CM
J Vet Pharmacol Ther; 2007 Feb; 30(1):74-9. PubMed ID: 17217405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]